Kentucky LEADS Collaborative: Lung Cancer Survivorship Care Program

Study summary

The objective of the Kentucky LEADS Lung Cancer Survivorship Care Program is to develop, administer and evaluate the impact of a comprehensive psychosocial survivorship care program for individuals diagnosed with lung cancer and their caregivers to improve lung cancer survivorship and delivery of high-quality lung cancer care. The investigators hypothesize that the Kentucky LEADS Lung Cancer Survivorship Care Program will demonstrate improved quality of life, better symptom control, increased tobacco treatment, and reduced distress among lung cancer survivors and their caregivers.

Ask AI to explain this study

Start here

Key things to know

Main goalSupportive Care

This describes the study’s primary purpose.

What is being studiedKY LEADS Survivorship Care

The study team can explain what participation involves.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Oct 29, 2020 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?9 U.S. locations

Locations may change over time.

Who runs it?Jamie Studts

Study sponsor

Study overview

What this study is about

Purpose: Supportive Care
Study type: Interventional
Phase: Not applicable
Sponsor: Jamie Studts
Interventions being studied: Behavioral: KY LEADS Survivorship Care

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Supportive or behavioral care→

Study topics

Survivorship and quality of life→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Individuals who have been diagnosed with lung cancer (survivor) or
Caregiver of a participating lung cancer survivor
Ability to read and write in English

Reasons someone may not be able to joinExclusion criteria

Individuals with significant psychiatric disturbance that requires a higher level of care
Individuals with substance abuse/dependence problem that require a higher level of care
Incarcerate individuals or individuals detained within the legal system

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Kings Daughters Medical Center - AshlandAshland, Kentucky
Commonwealth Cancer Center - DanvilleDanville, Kentucky
Hardin Memorial Health - ElizabethtownElizabethtown, Kentucky
Hazard ARH Regional Medical CenterHazard, Kentucky
Markey Cancer CenterLexington, Kentucky
UofL/Brown Cancer Center - LouisvilleLouisville, Kentucky
Baptist Health - MadisonvilleMadisonville, Kentucky
St. Claire Regional Medical Center - MoreheadMorehead, Kentucky
Owensboro HealthOwensboro, Kentucky

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 29, 2020. Always confirm current availability with the study team.

View original record ↗